CTI BioPharma prices underwritten public offering of $60 million of common stock
CTI BioPharma announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock, at a public offering price of $3.00 per share of common stock. CTI BioPharma ranted underwriters a 30-day option to purchase up to an additional 3,000,000 shares of common stock. February 09, 2018